0.91% 0.02

Oramed Pharmaceuticals Inc (ORMP)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Oramed Pharmaceuticals Inc-Aktie (ORMP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	2.00	-	-	-
Cost Of Revenue	100.00% -	1.987	-	-	-
Gross Profit	100.00% -	0.013	-	-	-
Operating Expenses	44.85% 2.489	4.513	-	-	-
Benefits Costs and Expenses	245.00% -13.13	9.058	-	-	-
Costs And Expenses	245.00% -13.13	9.058	-	-	-
Operating Income/Loss	44.69% -2.489	-4.50	-3.595	-3.089	-3.135
Nonoperating Income/Loss	700.70% 15.37	-2.558	-6.188	-15.42	14.23
Income/Loss From Continuing Operations Before Tax	286.09% 13.13	-7.058	-9.783	-18.51	10.84
Income Tax Expense/Benefit	121.58% -0.126	0.584	0.416	1.133	1.634
Income/Loss From Continuing Operations After Tax	273.51% 13.26	-7.642	-10.20	-19.64	9.204
Net Income/Loss	273.51% 13.26	-7.642	-10.16	-19.64	9.204
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-0.028	-	0.076	-0.023	-0.008
Basic Average Shares	1.25% 41.74	41.23	-0.0537	40.90	40.96
Diluted Average Shares	3.35% 42.61	41.23	-0.0537	40.90	41.59
Basic Earnings Per Share	268.42% 0.32	-0.19	-0.26	-0.48	0.22
Diluted Earnings Per Share	263.16% 0.31	-0.19	-0.26	-0.48	0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$85.44

1.75%

GMAB

$27.38

1.11%

SMMT

$23.80

1.19%

BNTX

$103.50

3.07%

INSM

$142.53

0.68%

ONC

$318.73

5.21%